Stockreport

NewcelX and Eledon partner for NCEL-101 programme [Yahoo! Finance]

Eledon Pharmaceuticals, Inc.  (ELDN) 
PDF NewcelX has signed a collaborative research agreement with Eledon Pharmaceuticals to advance its NCEL-101 programme for type 1 diabetes (T1D). The collaboration will [Read more]